Planar bioadhesive microdevices: A new technology for oral drug delivery

Current Pharmaceutical Biotechnology

Volumn 15, Issue 7, 2014, Pages 673-683

  Fox, Cade B ^a   Chirra, Hariharasudhan D ^a   Desai, Tejal A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bio MEMS; Microdevices; Microfabrication; Micropatches; Nanofabrication; Oral drug delivery

Indexed keywords

LIPOSOME; SOLID LIPID NANOPARTICLE; DRUG;

ARTICLE; BIOADHESIVE MICRODEVICE; BIOCOMPATIBILITY; CHEMICAL MODIFICATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG TRANSPORT; GASTROINTESTINAL TRACT FUNCTION; IN VITRO STUDY; MICROTECHNOLOGY; ORAL DRUG DELIVERY; PHOTOLITHOTROPH; PROCESS OPTIMIZATION; ADHESION; ANIMAL; CHEMISTRY; HUMAN; ORAL DRUG ADMINISTRATION;

ADHESIVENESS; ADMINISTRATION, ORAL; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 84924544942     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201015666140915152706     Document Type: Article

References (103)

1. International Transporter Consortium; Giacomini, K.M.; Huang, S.M.; Tweedie, D.J.; Benet, L.Z.; Brouwer, K.L.; Chu, X.; Dahlin, A.; Evers, R.; Fischer, V.; Hillgren, K.M.; Hoffmaster, K.A.; Ishikawa, T.; Keppler, D.; Kim, R.B.; Lee, C.A.; Niemi, M.; Polli, J.W.; Sugiyama, Y.; Swaan, P.W.; Ware, J.A.; Wright, S.H.; Yee, S.W.; Zamek-Gliszczynski, M.J.; Zhang, L. Membrane transporters in drug development. Nat. Rev. Drug Discov., 2010, 9(3), 215-236.
2. Thanki, K.; Gangwal, R.P.; Sangamwar, A.T.; Jain, S. Oral delivery of anticancer drugs: challenges and opportunities. J. Controlled Release, 2013, 170(1), 15-40.
3. Goldberg, M.; Gomez-Orellana, I. Challenges for the oral delivery of macromolecules. Nat. Rev. Drug Discov., 2003, 2(4), 289-295.
4. Gupta, S.; Jain, A.; Chakraborty, M.; Sahni, J.K.; Ali, J.; Dang, S. Oral delivery of therapeutic proteins and peptides: a review on recent developments. Drug Deliv., 2013, 20(6), 237-46.
5. Agrawal, U.; Sharma, R.; Gupta, M.; Vyas, S.P. Is nanotechnology a boon for oral drug delivery? Drug Discov. Today, 2014, S1359-6446(14)00148-2.
6. Felton, L.A.; Porter, S.C. An update on pharmaceutical film coating for drug delivery. Exp.Opin. Drug Deliv., 2013, 10(4), 421-435.
7. Kriegel, C.; Attarwala, H.; Amiji, M. Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract. Adv. Drug Deliv. Rev., 2013, 65(6), 891-901.
8. Hunter, A.C.; Elsom, J.; Wibroe, P.P.; Moghimi, S.M. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective. Nanomed. : Nanotech., Biol., Med., 2012, 8(Suppl 1), S5-20.
9. Dahan, A.; Khamis, M.; Agbaria, R.; Karaman, R. Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach. Expert Opin. Drug Deliv., 2012, 9(8), 1001-1013.
10. Zee, Y.K.; Goh, B.C.; Lee, S.C. Pharmacologic modulation strategies to reduce dose requirements of anticancer therapy while preserving clinical efficacy. Fut. Oncol., 2012, 8(6), 731-749.
11. Kuppens, I.E.; Breedveld, P.; Beijnen, J.H.; Schellens, J.H. Modulation of oral drug bioavailability: from preclinical mechanism to therapeutic application. Canc. Investi., 2005, 23(5), 443-464.
12. Lemmer, H.J.; Hamman, J.H. Paracellular drug absorption enhancement through tight junction modulation. Expert Opin. Drug Deliv., 2013, 10(1), 103-114.
13. Kararli, T.T. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharma. Drug Dispos., 1995, 16(5), 351-380.
14. Allen, A.; Flemstrom, G.; Garner, A.; Kivilaakso, E. Gastroduodenal mucosal protection. Physiol. Rev., 1993, 73(4), 823-857.
15. Atuma, C.; Strugala, V.; Allen, A.; Holm, L. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am. J. Physiol. Gastrointest. Liver Physiol., 2001, 280(5), G922-929.
16. Gustafsson, J.K.; Ermund, A.; Johansson, M.E.; Schutte, A.; Hansson, G.C.; Sjovall, H. An ex vivo method for studying mucus formation, properties, and thickness in human colonic biopsies and mouse small and large intestinal explants. Am. J. Physiol. Gastrointest. Liver Physiol., 2012, 302(4), G430-438.
17. Pries, A.R.; Secomb, T.W.; Gaehtgens, P. The endothelial surface layer. Pflugers Archiv : Eur. J. Physiol., 2000, 440(5), 653-666.
18. van den Berg, B.M.; Nieuwdorp, M.; Stroes, E.S.; Vink, H. Glycocalyx and endothelial (dys) function: from mice to men. Pharmacol. Rep. PR, 2006, 58(Suppl), 75-80.
19. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 2001, 46(1-3), 3-26.
20. Mayor, S.; Pagano, R.E. Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol., 2007, 8(8), 603-612.
21. Le Roy, C.; Wrana, J.L. Clathrin-and non-clathrin-mediated endocytic regulation of cell signalling. Nat. Rev. Mol. Cell Biol., 2005, 6(2), 112-126.
22. Pantzar, N.; Lundin, S.; Wester, L.; Westrom, B.R. Bidirectional small-intestinal permeability in the rat to some common marker molecules in vitro. Scand. J. Gastroenterol., 1994, 29(8), 703-709.
23. Salama, N.N.; Eddington, N.D.; Fasano, A. Tight junction modulation and its relationship to drug delivery. Adv. Drug Deliv. Rev., 2006, 58(1), 15-28.
24. Tang, R.; Li, W.X.; Huang, W.; Yan, F.; Chai, W.M.; Yang, G.Y.; Chen, K.M. CO2-based in-line phase contrast imaging of small intestine in mice. Scien. Rep., 2013, 3, 2313.
25. Sant, S.; Tao, S.L.; Fisher, O.Z.; Xu, Q.; Peppas, N.A.; Khademhosseini, A. Microfabrication technologies for oral drug delivery. Adv. Drug Deliv. Rev., 2012, 64(6), 496-507.
26. Chirra, H.D.; Desai, T.A. Emerging microtechnologies for the development of oral drug delivery devices. Adv. Drug Deliv. Rev., 2012, 64(14), 1569-1578.
27. Ainslie, K.M.; Lowe, R.D.; Beaudette, T.T.; Petty, L.; Bachelder, E.M.; Desai, T.A. Microfabricated devices for enhanced bioadhesive drug delivery: Attachment to and small-molecule release through a cell monolayer under flow. Small, 2009, 5(24), 2857-2863.
28. Tachibana, T.; Kato, M.; Takano, J.; Sugiyama, Y. Predicting drugdrug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein. Curr. Drug Metab., 2010, 11(9), 762-777.
29. Konig, J.; Muller, F.; Fromm, M.F. Transporters and drug-drug interactions: important determinants of drug disposition and effects. Pharmacol. Rev., 2013, 65(3), 944-966.
30. Besheer, A.; Wood, K.M.; Peppas, N.A.; Mader, K. Loading and mobility of spin-labeled insulin in physiologically responsive complexation hydrogels intended for oral administration. J. Control Release, 2006, 111(1-2), 73-80.
31. Kim, B.; Peppas, N.A. In vitro release behavior and stability of insulin in complexation hydrogels as oral drug delivery carriers. Int. J. Pharma., 2003, 266(1-2), 29-37.
32. Lowman, A.M.; Morishita, M.; Kajita, M.; Nagai, T.; Peppas, N.A. Oral delivery of insulin using pH-responsive complexation gels. J. Pharm. Sci., 1999, 88(9), 933-937.
33. Al-Hilal, T.A.; Alam, F.; Byun, Y. Oral drug delivery systems using chemical conjugates or physical complexes. Adv. Drug Deliv. Rev., 2013, 65(6), 845-864.
34. Chirra, H.D.; Desai, T.A. Multi-reservoir bioadhesive microdevices for independent rate-controlled delivery of multiple drugs. Small, 2012, 8(24), 3839-3846.
35. Tao, S.L.; Desai, T.A. Micromachined devices: the impact of controlled geometry from cell-targeting to bioavailability. J. Control Release, 2005, 109(1-3), 127-138.
36. Tao, S.L.; Popat, K.; Desai, T.A. Off-wafer fabrication and surface modification of asymmetric 3D SU-8 microparticles. Nat. Protoc., 2006, 1(6), 3153-3158.
37. Harris, L.A.; Hansel, S.; Di Baise, J.; Crowell, M.D. Irritable bowel syndrome and chronic constipation: emerging drugs, devices, and surgical treatments. Curr. Gastroenterol. Rep., 2006, 8(4), 282-290.
38. Wald, A. Irritable bowel syndrome--diarrhoea. Best Prac. Res. Clin. Gastroenterol., 2012, 26(5), 573-580.
39. Wilson, D.S.; Dalmasso, G.; Wang, L.; Sitaraman, S.V.; Merlin, D.; Murthy, N. Orally delivered thioketal nanoparticles loaded with TNF-alpha-siRNA target inflammation and inhibit gene expression in the intestines. Nat. Mat., 2010, 9(11), 923-8.
40. Ahmed, A.; Bonner, C.; Desai, T.A. Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery. J. Controlled Release., 2002, 81(3), 291-306.
41. Foraker, A.B.; Walczak, R.J.; Cohen, M.H.; Boiarski, T.A.; Grove, C.F.; Swaan, P.W. Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers. Pharma. Res., 2003, 20(1), 110-116.
42. Hiebl, B.; Hopperdietzel, C.; Hunigen, H.; Jung, F.; Scharnagl, N. Influence of a silicon (Si14)-based coating substrate for biomaterials on fibroblast growth and human C5a. Clin. Hemorheol. Microcirc., 2013, 55(4), 491-499.
43. Peng, F.; Su, Y.; Zhong, Y.; Fan, C.; Lee, S.T.; He, Y. Silicon nanomaterials platform for bioimaging, biosensing, and cancer therapy. Acc. Chem. Res., 2014, 47(2), 612-623.
44. Santos, H.A.; Makila, E.; Airaksinen, A.J.; Bimbo, L.M.; Hirvonen, J. Porous silicon nanoparticles for nanomedicine: Preparation and biomedical applications. Nanomed., 2014, 9(4), 535-554.
45. Fubini, B.; Hubbard, A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Rad. Biol. Med., 2003, 34(12), 1507-1516.
46. Tungjai, M.; Whorton, E.B.; Rithidech, K.N. Persistence of apoptosis and inflammatory responses in the heart and bone marrow of mice following whole-body exposure to (2)(8)Silicon ((2)(8)Si) ions. Radiation Environ. Biophys., 2013, 52(3), 339-350.
47. Food; Drug Administration, H.H.S. Medical devices; reclassification of polymethylmethacrylate (PMMA) bone cement. Final rule. Fed. Reg., 2002, 67(137), 46852-46855.
48. Xu, Y.; Xie, F.; Qiu, T.; Xie, L.; Xing, W.; Cheng, J. Rapid fabrication of a microdevice with concave microwells and its application in embryoid body formation. Biomicrofluidics, 2012, 6(1), 16504-1650411.
49. Reedy, C.R.; Price, C.W.; Sniegowski, J.; Ferrance, J.P.; Begley, M.; Landers, J.P. Solid phase extraction of DNA from biological samples in a post-based, high surface area poly(methyl methacrylate) (PMMA) microdevice. Lab Chip, 2011, 11(9), 1603-1611.
50. Tao, S.L.; Lubeley, M.W.; Desai, T.A. Bioadhesive poly(methyl methacrylate) microdevices for controlled drug delivery. J. Control Release, 2003, 88(2), 215-228.
51. Wei, S.; Vaidya, B.; Patel, A.B.; Soper, S.A.; McCarley, R.L. Photochemically patterned poly(methyl methacrylate) surfaces used in the fabrication of microanalytical devices. J. Physi. Chem. B, 2005, 109(35), 16988-16996.
52. Ainslie, K.M.; Kraning, C.M.; Desai, T.A. Microfabrication of an asymmetric, multi-layered microdevice for controlled release of orally delivered therapeutics. Lab Chip, 2008, 8(7), 1042-1047.
53. Kotzar, G.; Freas, M.; Abel, P.; Fleischman, A.; Roy, S.; Zorman, C.; Moran, J.M.; Melzak, J. Evaluation of MEMS materials of construction for implantable medical devices. Biomater., 2002, 23(13), 2737-2750.
54. Voskerician, G.; Shive, M.S.; Shawgo, R.S.; von Recum, H.; Anderson, J.M.; Cima, M.J.; Langer, R. Biocompatibility and biofouling of MEMS drug delivery devices. Biomater., 2003, 24(11), 1959-1967.
55. Vernekar, V.N.; Cullen, D.K.; Fogleman, N.; Choi, Y.; Garcia, A.J.; Allen, M.G.; Brewer, G.J.; La Placa, M.C. SU-8 2000 rendered cytocompatible for neuronal bioMEMS applications. J. Biomed. Mater. Res. Part A, 2009, 89(1), 138-151.
56. Guan, J.; He, H.; Lee, L.J.; Hansford, D.J. Fabrication of particulate reservoir-containing, capsulelike, and self-folding polymer microstructures for drug delivery. Small, 2007, 3(3), 412-418.
57. Tao, S.L.; Desai, T.A. Microfabrication of multilayer, asymmetric, polymeric devices for drug delivery. Adv. Mater., 2005, 17(13), 1625-+.
58. Ryu, W.H.; Vyakarnam, M.; Greco, R.S.; Prinz, F.B.; Fasching, R.J. Fabrication of multi-layered biodegradable drug delivery device based on micro-structuring of PLGA polymers. Biomed. Microdev., 2007, 9(6), 845-853.
59. Guan, J.J.; Chakrapani, A.; Hansford, D.J. Polymer microparticles fabricated by soft lithography. Chem. Mater., 2005, 17(25), 6227-6229.
60. Guan, J.; He, H.; Hansford, D.J.; Lee, L.J. Self-folding of threedimensional hydrogel microstructures. J. Physical Chem. B, 2005, 109(49), 23134-23137.
61. He, H.; Cao, X.; Lee, L.J. Design of a novel hydrogel-based intelligent system for controlled drug release. J. Controlled Release, 2004, 95(3), 391-402.
62. Ito, Y.; Hasuda, H.; Morimatsu, M.; Takagi, N.; Hirai, Y. A microfabrication method of a biodegradable polymer chip for a controlled release system. J. Biomat. Sci. Polymer Ed., 2005, 16(8), 949-955.
63. Norman, J.J.; Desai, T.A. Methods for fabrication of nanoscale topography for tissue engineering scaffolds. Annals Biomed. Engg., 2006, 34(1), 89-101.
64. Qian, T.; Wang, Y. Micro/nano-fabrication technologies for cell biology. Med. Biol. Engg. Comp., 2010, 48(10), 1023-1032.
65. Ziaie, B.; Baldi, A.; Lei, M.; Gu, Y.; Siegel, R.A. Hard and soft micromachining for BioMEMS: review of techniques and examples of applications in microfluidics and drug delivery. Adv. Drug Deliv. Rev., 2004, 56(2), 145-172.
66. Chirra, H.D.; Shao, L.; Ciaccio, N.; Fox, C.B.; Wade, J.M.; Ma, A.; Desai, T.A. Planar Microdevices for Enhanced In Vivo Retention and Oral Bioavailability of Poorly Permeable Drugs. Adv. Healthcare Mat., 2014.
67. Tao, S.L.; Desai, T.A. Gastrointestinal patch systems for oral drug delivery. Drug Discov. Today, 2005, 10(13), 909-915.
68. Guan, J.; Ferrell, N.; James Lee, L.; Hansford, D.J. Fabrication of polymeric microparticles for drug delivery by soft lithography. Biomater., 2006, 27(21), 4034-4041.
69. Jackman, R.J.; Duffy, D.C.; Ostuni, E.; Willmore, N.D.; Whitesides, G.M. Fabricating large arrays of microwells with arbitrary dimensions and filling them using discontinuous dewetting. Analyt. Chem., 1998, 70(11), 2280-2287.
70. Ferrell, N.; Woodard, J.; Hansford, D. Fabrication of polymer microstructures for MEMS: sacrificial layer micromolding and patterned substrate micromolding. Biomed. Microdev., 2007, 9(6), 815-821.
71. Geipel, A.; Goldschmidtboeing, F.; Jantscheff, P.; Esser, N.; Massing, U.; Woias, P. Design of an implantable active microport system for patient specific drug release. Biomed. Microdev., 2008, 10(4), 469-478.
72. Husler, R.; Schlittler, F.L.; Kreutziger, J.; Streit, M.; Banic, A.; Schoni-Affolter, F.; Hunger, R.E.; Constaninescu, M.A. Staged surgical therapy of basal cell carcinoma of the head and neck region: an evaluation of 500 procedures. Swiss Med. Weekly, 2008, 138(49-50), 746-751.
73. Lu, X.; Kim-Han, J.S.; O'Malley, K.L.; Sakiyama-Elbert, S.E. A microdevice platform for visualizing mitochondrial transport in aligned dopaminergic axons. J. Neurosci. Methods, 2012, 209(1), 35-39.
74. Park, J.; Li, J.; Han, A. Micro-macro hybrid soft-lithography master (MMHSM) fabrication for lab-on-a-chip applications. Biomed. Microdev., 2010, 12(2), 345-351.
75. Fischer, K.E.; Nagaraj, G.; Hugh Daniels, R.; Li, E.; Cowles, V.E.; Miller, J.L.; Bunger, M.D.; Desai, T.A. Hierarchical nanoengineered surfaces for enhanced cytoadhesion and drug delivery. Biomater., 2011, 32(13), 3499-3506.
76. Uskokovic, V.; Lee, K.; Lee, P.P.; Fischer, K.E.; Desai, T.A. Shape effect in the design of nanowire-coated microparticles as transepithelial drug delivery devices. ACS Nano, 2012, 6(9), 7832-7841.
77. Uskokovic, V.; Lee, P.P.; Walsh, L.A.; Fischer, K.E.; Desai, T.A. PEGylated silicon nanowire coated silica microparticles for drug delivery across intestinal epithelium. Biomater., 2012, 33(5), 1663-1672.
78. Kam, K.R.; Walsh, L.A.; Bock, S.M.; Koval, M.; Fischer, K.E.; Ross, R.F.; Desai, T.A. Nanostructure-mediated transport of biologics across epithelial tissue: enhancing permeability via nanotopography. Nano Lett., 2013, 13(1), 164-171.
79. Lohmuller, T.; Aydin, D.; Schwieder, M.; Morhard, C.; Louban, I.; Pacholski, C.; Spatz, J.P. Nanopatterning by block copolymer micelle nanolithography and bioinspired applications. Biointerph., 2011, 6(1), MR1-12.
80. Marmiroli, B.; Amenitsch, H. X-ray lithography and small-angle X-ray scattering: a combination of techniques merging biology and materials science. Eur. Biophy., 2012, 41(10), 851-861.
81. Betancourt, T.; Brannon-Peppas, L. Micro-and nanofabrication methods in nanotechnological medical and pharmaceutical devices. Int. J. Nanomed., 2006, 1(4), 483-495.
82. Chen, Y.; Pepin, A. Nanofabrication: conventional and nonconventional methods. Electropho., 2001, 22(2), 187-207.
83. Hu, W.C.; Sarveswaran, K.; Lieberman, M.; Bernstein, G.H. Sub-10 nm electron beam lithography using cold development of poly(methylmethacrylate). J. Vac. Sci. Technol. B, 2004, 22(4), 1711-1716.
84. Pulsifer, D.P.; Lakhtakia, A. Background and survey of bioreplication techniques. Bioinsp. Biomim., 2011, 6(3), 031001.
85. Wu, C.C.; Reinhoudt, D.N.; Otto, C.; Subramaniam, V.; Velders, A.H. Strategies for patterning biomolecules with dip-pen nanolithography. Small, 2011, 7(8), 989-1002.
86. Chou, S.Y.; Krauss, P.R. Imprint lithography with sub-10 nm feature size and high throughput. Microelectron Eng., 1997, 35(1-4), 237-240.
87. Chou, S.Y.; Krauss, P.R.; Renstrom, P.J. Imprint lithography with 25-nanometer resolution. Science, 1996, 272(5258), 85-87.
88. Lan, H.; Liu, H. UV-nanoimprint lithography: structure, materials and fabrication of flexible molds. J. Nanosci. Nanotechnol., 2013, 13(5), 3145-3172.
89. Truskett, V.N.; Watts, M.P. Trends in imprint lithography for biological applications. Trends Biotechnol., 2006, 24(7), 312-317.
90. Fischer, K.E.; Aleman, B.J.; Tao, S.L.; Hugh Daniels, R.; Li, E.M.; Bunger, M.D.; Nagaraj, G.; Singh, P.; Zettl, A.; Desai, T.A. Biomimetic nanowire coatings for next generation adhesive drug delivery systems. Nano Lett., 2009, 9(2), 716-720.
91. Porter, J.R.; Henson, A.; Popat, K.C. Biodegradable poly(epsiloncaprolactone) nanowires for bone tissue engineering applications. Biomater., 2009, 30(5), 780-788.
92. Wood, K.M.; Stone, G.M.; Peppas, N.A. The effect of complexation hydrogels on insulin transport in intestinal epithelial cell models. Acta Biomaterialia, 2010, 6(1), 48-56.
93. Arbos, P.; Arangoa, M.A.; Campanero, M.A.; Irache, J.M. Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles. Int. J. Pharma., 2002, 242(1-2), 129-136.
94. Amidi, M.; Mastrobattista, E.; Jiskoot, W.; Hennink, W.E. Chitosan-based delivery systems for protein therapeutics and antigens. Adv. Drug Deliv. Rev., 2010, 62(1), 59-82.
95. Bariya, S.H.; Gohel, M.C.; Mehta, T.A.; Sharma, O.P. Microneedles: an emerging transdermal drug delivery system. J. Pharma. Pharmacol., 2012, 64(1), 11-29.
96. Escobar-Chavez, J.J.; Bonilla-Martinez, D.; Villegas-Gonzalez, M.A.; Molina-Trinidad, E.; Casas-Alancaster, N.; Revilla-Vazquez, A.L. Microneedles: a valuable physical enhancer to increase transdermal drug delivery. J. Clin. Pharmacol., 2011, 51(7), 964-977.
97. Illum, L. Chitosan and its use as a pharmaceutical excipient. Pharma. Res., 1998, 15(9), 1326-1331.
98. Kumar, M.N.; Muzzarelli, R.A.; Muzzarelli, C.; Sashiwa, H.; Domb, A.J. Chitosan chemistry and pharmaceutical perspectives. Chem. Rev., 2004, 104(12), 6017-6084.
99. Patel, M.P.; Patel, R.R.; Patel, J.K. Chitosan mediated targeted drug delivery system: a review. J. Pharm. Pharmaceut. Sci., 2010, 13(4), 536-557.
100. Marizza, P.; Keller, S.S.; Boisen, A. Inkjet printing as a technique for filling of micro-wells with biocompatible polymers. Microelectron Eng., 2013, 111, 391-395.
101. Marizza, P.; Keller, S.S.; Mullertz, A.; Boisen, A. Polymer-filled microcontainers for oral delivery loaded using supercritical impregnation. J. Controlled Release, 2014, 173, 1-9.
102. Fischer, K.E.; Jayagopal, A.; Nagaraj, G.; Daniels, R.H.; Li, E.M.; Silvestrini, M.T.; Desai, T.A. Nanoengineered surfaces enhance drug loading and adhesion. Nano Lett., 2011, 11(3), 1076-1081.
103. Ainslie, K.M.; Desai, T.A. Microfabricated implants for applications in therapeutic delivery, tissue engineering, and biosensing. Lab. Chip, 2008, 8(11), 1864-1878.